Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 256
Filter
1.
Diabetologia ; 56(6): 1339-49, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23568272

ABSTRACT

AIMS/HYPOTHESIS: Phosphatidylinositol 3-OH kinases (PI3Ks) regulate beta cell mass, gene transcription, and function, although the contribution of the specific isoforms is unknown. As reduced type 1A PI3K signalling is thought to contribute to impaired insulin secretion, we investigated the role of the type 1A PI3K catalytic subunits α and ß (p110α and -ß) in insulin granule recruitment and exocytosis in rodent and human islets. METHODS: The p110α and p110ß subunits were inhibited pharmacologically or by small hairpin (sh)RNA-mediated knockdown, and were directly infused or overexpressed in mouse and human islets, beta cells and INS-1 832/13 cells. Glucose-stimulated insulin secretion (GSIS), single-cell exocytosis, Ca(2+) signalling, plasma membrane granule localisation, and actin density were monitored. RESULTS: Inhibition or knockdown of p110α increased GSIS. This was not due to altered Ca(2+) responses, depolymerisation of cortical actin or increased cortical granule density, but to enhanced Ca(2+)-dependent exocytosis. Intracellular infusion of recombinant PI3Kα (p110α/p85ß) blocked exocytosis. Conversely, knockdown (but not pharmacological inhibition) of p110ß blunted GSIS, reduced cortical granule density and impaired exocytosis. Exocytosis was rescued by direct intracellular infusion of recombinant PI3Kß (p110ß/p85ß) even when p110ß catalytic activity was inhibited. Conversely, both the wild-type p110ß and a catalytically inactive mutant directly facilitated exocytosis. CONCLUSIONS/INTERPRETATION: Type 1A PI3K isoforms have distinct and opposing roles in the acute regulation of insulin secretion. While p110α acts as a negative regulator of beta cell exocytosis and insulin secretion, p110ß is a positive regulator of insulin secretion through a mechanism separate from its catalytic activity.


Subject(s)
Class Ia Phosphatidylinositol 3-Kinase/metabolism , Insulin-Secreting Cells/metabolism , Insulin/metabolism , Animals , Calcium Signaling , Catalytic Domain , Cell Membrane/metabolism , Enzyme Inhibitors/pharmacology , Exocytosis , Humans , Insulin Secretion , Male , Mice , Mice, Inbred C57BL , Middle Aged , Protein Isoforms/metabolism , RNA, Small Interfering/metabolism , Signal Transduction
2.
Diabetologia ; 55(6): 1709-20, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22411134

ABSTRACT

AIMS/HYPOTHESIS: It is thought that the voltage-dependent potassium channel subunit Kv2.1 (Kv2.1) regulates insulin secretion by controlling beta cell electrical excitability. However, this role of Kv2.1 in human insulin secretion has been questioned. Interestingly, Kv2.1 can also regulate exocytosis through direct interaction of its C-terminus with the soluble NSF attachment receptor (SNARE) protein, syntaxin 1A. We hypothesised that this interaction mediates insulin secretion independently of Kv2.1 electrical function. METHODS: Wild-type Kv2.1 or mutants lacking electrical function and syntaxin 1A binding were studied in rodent and human beta cells, and in INS-1 cells. Small intracellular fragments of the channel were used to disrupt native Kv2.1-syntaxin 1A complexes. Single-cell exocytosis and ion channel currents were monitored by patch-clamp electrophysiology. Interaction between Kv2.1, syntaxin 1A and other SNARE proteins was probed by immunoprecipitation. Whole-islet Ca(2+)-responses were monitored by ratiometric Fura red fluorescence and insulin secretion was measured. RESULTS: Upregulation of Kv2.1 directly augmented beta cell exocytosis. This happened independently of channel electrical function, but was dependent on the Kv2.1 C-terminal syntaxin 1A-binding domain. Intracellular fragments of the Kv2.1 C-terminus disrupted native Kv2.1-syntaxin 1A interaction and impaired glucose-stimulated insulin secretion. This was not due to altered ion channel activity or impaired Ca(2+)-responses to glucose, but to reduced SNARE complex formation and Ca(2+)-dependent exocytosis. CONCLUSIONS/INTERPRETATION: Direct interaction between syntaxin 1A and the Kv2.1 C-terminus is required for efficient insulin exocytosis and glucose-stimulated insulin secretion. This demonstrates that native Kv2.1-syntaxin 1A interaction plays a key role in human insulin secretion, which is separate from the channel's electrical function.


Subject(s)
Insulin/metabolism , Islets of Langerhans/metabolism , Shab Potassium Channels/metabolism , Animals , Cell Line, Tumor , Cells, Cultured , Electrophysiology , Humans , Immunoblotting , Immunoprecipitation , Insulin Secretion , Mice , Protein Binding , Rats , Shab Potassium Channels/genetics , Syntaxin 1/metabolism
3.
Br J Pharmacol ; 151(4): 483-93, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17435793

ABSTRACT

BACKGROUND AND PURPOSE: Some non-steroidal anti-inflammatory drugs (NSAIDs) incidentally induce hypoglycemia, which is often seen in diabetic patients receiving sulphonylureas. NSAIDs influence various ion channel activities, thus they may cause hypoglycemia by affecting ion channel functions in insulin secreting beta cells. This study investigated the effects of the NSAID meclofenamic acid (MFA) on the electrical excitability and the secretion of insulin from pancreatic beta cells. EXPERIMENTAL APPROACH: Using patch clamp techniques and insulin secretion assays, the effects of MFA on the membrane potential and transmembrane current of INS-1 cells, and insulin secretion were studied. KEY RESULTS: Under perforated patch recordings, MFA induced a rapid depolarization in INS-1 cells bathed in low (2.8 mM), but not high (28 mM) glucose solutions. MFA, as well as acetylsalicylic acid (ASA) and flufenamic acid (FFA), excited the cells by inhibiting ATP-sensitive potassium channels (K(ATP)). In whole cell recordings, K(ATP) conductance consistently appeared when intracellular ATP was diluted. Intracellular glibenclamide prevented the development of K(ATP) activity, whereas intracellular MFA had no effect. At low glibenclamide concentrations, MFA induced additional inhibition of the K(ATP) current. Live cell Ca(2+) imaging displayed that MFA elevated intracellular Ca(2+) at low glucose concentrations. Furthermore, MFA dose-dependently increased insulin release under low, but not high, glucose conditions. CONCLUSIONS AND IMPLICATIONS: MFA blocked K(ATP) through an extracellular mechanism and thus increased insulin secretion. As some NSAIDs synergistically inhibit K(ATP) activity together with sulphonylureas, the risk of NSAID-induced hypoglycemia should be considered when glucose-lowering compounds are administered.


Subject(s)
Adenosine Triphosphate/pharmacology , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Insulin-Secreting Cells/drug effects , Insulin/metabolism , Meclofenamic Acid/pharmacology , Potassium Channel Blockers/pharmacology , Animals , Calcium/metabolism , Cells, Cultured , Glucose/pharmacology , Insulin Secretion , Insulin-Secreting Cells/metabolism , Insulin-Secreting Cells/physiology , Membrane Potentials/drug effects , Mice
4.
J Endocrinol ; 190(3): 669-80, 2006 Sep.
Article in English | MEDLINE | ID: mdl-17003268

ABSTRACT

We investigated whether an increase in cAMP could normalize glucose-stimulated insulin secretion (GSIS) in uncoupling protein-2 (UCP2) overexpressing (ucp2-OE) beta-cells. Indices of beta-cell (beta-TC-6f7 cells and rodent islets) function were measured after induction of ucp2, in the presence or absence of cAMP-stimulating agents, analogs, or inhibitors. Islets of ob/ob mice had improved glucose-responsiveness in the presence of forskolin. Rat islets overexpressing ucp2 had significantly lower GSIS than controls. Acutely, the protein kinase A (PKA) and epac pathway stimulant forskolin normalized insulin secretion in ucp2-OE rat islets and beta-TC-6f7 beta-cells, an effect blocked by specific PKA inhibitors but not mimicked by epac agonists. However, there was no effect of ucp2-OE on cAMP concentrations or PKA activity. In ucp2-OE islets, forskolin inhibited ATP-dependent potassium (K(ATP)) channel currents and (86)Rb(+) efflux, indicative of K(ATP) block. Likewise, forskolin application increased intracellular Ca(2+), which could account for its stimulatory effects on insulin secretion. Chronic exposure to forskolin increased ucp2 mRNA and exaggerated basal secretion but not GSIS. In mice deficient in UCP2, there was no augmentation of either cAMP content or cAMP-dependent insulin secretion. Thus, elevating cellular cAMP can reverse the deficiency in GSIS invoked by ucp2-OE, at least partly through PKA-mediated effects on the K(ATP) channel.


Subject(s)
Cyclic AMP/metabolism , Glucose/pharmacology , Insulin-Secreting Cells/metabolism , Insulin/metabolism , Ion Channels/metabolism , Mitochondrial Proteins/metabolism , Signal Transduction/physiology , Adenosine Triphosphate/metabolism , Animals , Calcium/metabolism , Cell Line , Colforsin/pharmacology , Cyclic AMP/analysis , Cyclic AMP-Dependent Protein Kinases/analysis , Cyclic AMP-Dependent Protein Kinases/metabolism , Female , Glucose/metabolism , Insulin Secretion , Ion Channels/genetics , Male , Mice , Mice, Knockout , Mitochondrial Proteins/genetics , Obesity/metabolism , Perfusion , Rats , Rats, Mutant Strains , Rats, Zucker , Stimulation, Chemical , Uncoupling Protein 2 , Up-Regulation
5.
Breast ; 12(6): 432-41, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14659118

ABSTRACT

The oestrogen receptor (ER) has proven to be an extraordinarily successful target for breast cancer treatment and prevention. The clinical use of tamoxifen, a nonsteroidal antioestrogen, demonstrated (1) that the strategic use of adjuvant tamoxifen in ER-positive patients could save lives and (2) that a selective ER modulator (SERM) could reduce the incidence of breast cancer in high-risk women. The ER is now the target for new and safer therapies such as the aromatase inhibitors and the pure antioestrogens that either block oestrogen synthesis or destroy the ER. However, the use of raloxifene, a SERM to prevent osteoporosis with the potential to prevent breast cancer has introduced a new dimension into preventive oncology. The widespread use of endocrine modulators (SERMs, aromatase inhibitors, and pure antioestrogens) raised the question of drug resistance. It is now clear that endocrine resistance can evolve through stages. Once a breast tumour becomes resistant to SERMs, the growth is stimulated by either the SERM or oestrogen. This is why an aromatase inhibitor is effective following SERM resistance and withdrawal. However, the extended use of repeated endocrine therapies now supersensitized the cells to oestrogen that causes apoptosis through the ER. We suggest that future clinical treatment strategies incorporate an 'oestrogen purge' to both enhance the actions of chemotherapy or completely reverse endocrine resistance and restore endocrine sensitivity. These new data build on the idea that breast cancer can be controlled as a chronic disease and will permit patients to live long and productive lives during targeted maintenance treatment.


Subject(s)
Breast Neoplasms/physiopathology , Receptors, Estrogen/physiology , Antineoplastic Agents, Hormonal/pharmacology , Antineoplastic Agents, Hormonal/therapeutic use , Breast Neoplasms/drug therapy , Breast Neoplasms/prevention & control , Drug Resistance , Female , Humans , Phosphorylation , Tamoxifen/pharmacology , Tamoxifen/therapeutic use
6.
Neuroscience ; 115(1): 251-61, 2002.
Article in English | MEDLINE | ID: mdl-12401338

ABSTRACT

The effect of quinine on pyramidal cell intrinsic properties, extracellular potassium transients, and epileptiform activity was studied in vitro using the rat hippocampal slice preparation. Quinine enhanced excitatory post-synaptic potentials and decreased fast- and slow-inhibitory post-synaptic potentials. Quinine reduced the peak potassium rise following tetanic stimulation but did not affect the potassium clearance rate. Epileptiform activity induced by either low-Ca(2+) or high-K(+) artificial cerebrospinal fluid (ACSF) was suppressed by quinine. The frequency of spontaneous inter-ictal bursting induced by picrotoxin, high-K(+), or 4-aminopyridine was significantly increased. In normal ACSF, quinine did not affect CA1 pyramidal cell resting membrane potential, input resistance, threshold for action potentials triggered by intracellular or extracellular stimulation, or the orthodromic and antidromic evoked population spike amplitude. The main effects of quinine on intrinsic cell properties were to increase action potential duration and to reduce firing frequency during sustained membrane depolarizations, but not at normal resting membrane potentials. This attenuation was enhanced at increasingly depolarized membrane potentials. These results suggest that quinine suppresses extracellular potassium transients and ictal activity and modulates inter-ictal activity by limiting the firing rate of cells in a voltage-dependent manner. Because quinine does not affect 'normal' neuronal function, it may merit consideration as an anticonvulsant.


Subject(s)
Epilepsy/physiopathology , Excitatory Postsynaptic Potentials/drug effects , Extracellular Space/drug effects , Neurons/drug effects , Potassium Channels/physiology , Quinine/pharmacology , Animals , Anticonvulsants/pharmacology , Epilepsy/drug therapy , Excitatory Postsynaptic Potentials/physiology , Extracellular Space/physiology , In Vitro Techniques , Male , Neurons/physiology , Quinine/therapeutic use , Rats , Rats, Sprague-Dawley
7.
Am J Med Genet ; 107(2): 174-6, 2002 Jan 15.
Article in English | MEDLINE | ID: mdl-11807894

ABSTRACT

Structural chromosome mosaicism is rare. We report a case of prenatal mosaicism for a deletion of chromosome 10(q23). To our knowledge, there are only three reports of prenatally diagnosed cases of del(10)(q23). Two of these cases were due to an inherited fragile site. In the present case amniocentesis revealed 46,XY,del(10)(q23)[9]/46,XY[45]. Follow-up chromosome analysis of peripheral blood and placental tissue from a phenotypically normal liveborn male revealed the del(10)(q23) in only 3/100 blood cells grown in low-folate medium. It appears that prenatally diagnosed deleted (10q) mosaicism represents culture artifact and is not clinically significant.


Subject(s)
Chromosome Deletion , Chromosomes, Human, Pair 10 , Mosaicism , Prenatal Diagnosis , Adult , Female , Humans , Karyotyping
8.
FASEB J ; 15(14): 2586-94, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11726534

ABSTRACT

The protective roles of sarcolemmal (sarc) and mitochondrial (mito) KATP channels are unclear despite their apparent importance to ischemic preconditioning. We examined these roles by monitoring intracellular calcium ([Ca]int), using fura-2 and fluo-3, in enzymatically isolated rat right ventricular myocytes. Myocyte mortality, estimated using a trypan blue assay, changed approximately in parallel with changes in [Ca]int. Chemically induced hypoxia (CIH), induced by application of cyanide and 2-deoxy-glucose, caused a steady rise in [Ca]int. Calcium increased more rapidly on 'reoxygenation' by return to control solutions. The protein kinase C (PKC) activator PMA abolished both phases of calcium increase. The mitoKATP channel-selective blocker 5-hydroxydecanoate partially prevented the PMA-induced protection during CIH, but not during reoxygenation. In contrast, HMR 1098, a sarcKATP channel-selective blocker, abolished protection only during the reoxygenation. Adenosine (A1) receptor activation prevented or reduced increases in [Ca]int and improved cell viability via a PKC and mito/sarcKATP channel-dependent mechanism. PKC-dependent protection against cytoplasmic calcium increases was also observed in a human cell line (tsA201) transiently expressing sarcKATP channels. Protection was abolished only during the reoxygenation phase by the amino acid substitution (T180A) in the pore-forming Kir6.2 subunit, a mutation previously shown to prevent PKC-dependent modulation. Our data suggest that sarc and mitoKATP channel populations play distinct protective roles, triggered by PKC and/or adenosine, during chemically induced hypoxia/reoxygenation.


Subject(s)
Adenosine/analogs & derivatives , Mitochondria/metabolism , Potassium Channels/physiology , Sarcolemma/metabolism , ATP-Binding Cassette Transporters , Adenosine/pharmacology , Adenosine Triphosphate/pharmacology , Animals , Benzamides/pharmacology , Calcium/metabolism , Cell Hypoxia/physiology , Cell Line , Cell Survival/drug effects , Cells, Cultured , Decanoic Acids/pharmacology , Dose-Response Relationship, Drug , Enzyme Activation/drug effects , Heart Ventricles/cytology , Heart Ventricles/drug effects , Humans , Hydroxy Acids/pharmacology , Ischemic Preconditioning, Myocardial , KATP Channels , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , Membrane Potentials/drug effects , Myocardium/metabolism , Oxygen/pharmacology , Potassium Channels/drug effects , Potassium Channels/genetics , Potassium Channels, Inwardly Rectifying , Purinergic P1 Receptor Agonists , Purinergic P1 Receptor Antagonists , Rats , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/physiology , Time Factors , Ventricular Function , Xanthines/pharmacology
9.
Nature ; 413(6852): 128-9, 2001 Sep 13.
Article in English | MEDLINE | ID: mdl-11557969

ABSTRACT

Nitrogen fixation is a symbiotic process initiated by chemical signals from legumes that are recognized by soil bacteria. Here we show that some endocrine-disrupting chemicals (EDCs), so called because of their effect on hormone-signalling pathways in animal cells, also interfere with the symbiotic signalling that leads to nitrogen fixation. Our results raise the possibility that these phytochemically activated pathways may have features in common with hormonal signalling in vertebrates, thereby extending the biological and ecological impact of EDCs.


Subject(s)
Hormones , Nitrogen Fixation , Pesticides/pharmacology , Phenols/pharmacology , Medicago sativa/microbiology , Medicago sativa/physiology , Pesticides/chemistry , Phenols/chemistry , Rhizobiaceae/physiology , Signal Transduction/drug effects , Symbiosis
10.
Biochem J ; 358(Pt 2): 379-87, 2001 Sep 01.
Article in English | MEDLINE | ID: mdl-11513736

ABSTRACT

Atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) exert their physiological actions by binding to natriuretic peptide receptor A (NPRA), a receptor guanylate cyclase (rGC) that synthesizes cGMP in response to both ligands. The family of rGCs is rapidly expanding, and it is plausible that there might be additional, as yet undiscovered, rGCs whose function is to provide alternative signalling pathways for one or both of these peptides, particularly given the low affinity of NPRA for BNP. We have investigated this hypothesis, using a genetically modified (knockout) mouse in which the gene encoding NPRA has been disrupted. Enzyme assays and NPRA-specific Western blots performed on tissues from wild-type mice demonstrate that ANP-activated cGMP synthesis provides a good index of NPRA protein expression, which ranges from maximal in adrenal gland, lung, kidney, and testis to minimal in heart and colon. In contrast, immunoreactive NPRA is not detectable in tissues isolated from NPRA knockout animals and ANP- and BNP-stimulatable GC activities are markedly reduced in all mutant tissues. However, testis and adrenal gland retain statistically significant, high-affinity responses to BNP. This residual response to BNP cannot be accounted for by natriuretic peptide receptor B, or any other known mammalian rGC, suggesting the presence of a novel receptor in these tissues that prefers BNP over ANP.


Subject(s)
Atrial Natriuretic Factor/pharmacology , Natriuretic Peptide, Brain/pharmacology , Receptors, Atrial Natriuretic Factor/metabolism , Adrenal Glands/metabolism , Animals , Blotting, Western , Cyclic GMP/biosynthesis , Guanylate Cyclase/genetics , Guanylate Cyclase/metabolism , Male , Mice , Mice, Knockout , Natriuretic Peptide, C-Type/pharmacology , Receptors, Atrial Natriuretic Factor/genetics , Testis/metabolism , Tissue Distribution
11.
Thromb Haemost ; 86(1): 198-213, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11487008

ABSTRACT

The actin filament network fills the cytoplasm of unstimulated platelets and connects with a submembranous latticework of short cross-linked actin filaments, known as the membrane skeleton. One function of the cytoskeleton is to direct the contours of the membrane in the unstimulated platelet and the rapid changes in shape in the activated platelet. Activation-induced changes result from events such as phosphorylation or calpain-induced cleavage of cytoskeletal proteins. The specific reorganizations depend upon the combination of signals to which platelets are exposed. A second function of the cytoskeleton is to bind other cellular components; it binds signaling molecules, localizing them to specific cellular locations; it binds the plasma membrane regulating properties of the membrane, maintaining microdomains in the membrane, or regulating activities of membrane proteins. In this way, the cytoskeleton plays a critical role in regulation of spatial organizations and, thus, in the integration of cellular activities.


Subject(s)
Blood Platelets/physiology , Cytoskeletal Proteins/physiology , Blood Platelets/chemistry , Blood Platelets/ultrastructure , Cytoskeletal Proteins/metabolism , Cytoskeleton/metabolism , Cytoskeleton/physiology , Humans , Membrane Microdomains , Signal Transduction
12.
J Biol Chem ; 276(30): 28300-8, 2001 Jul 27.
Article in English | MEDLINE | ID: mdl-11382766

ABSTRACT

Recently we showed that signaling across beta3-integrin leads to activation of calpain and formation of integrin clusters that are involved in Rac activation. The subsequent activation of Rac and Rho leads to the formation of focal complexes and focal adhesions, respectively. The goal of the present study was to determine whether different proteins link the integrin to the cytoskeleton in the different complexes. We show that talin is present in focal adhesions but not in the calpain-induced clusters. alpha-Actinin colocalized with integrin at various sites, including the calpain-induced clusters. Skelemin, a protein shown recently to interact with beta1- and beta3-integrin in vitro, colocalized with integrin in calpain-induced clusters but was absent from focal adhesions. Cells transiently expressing skelemin C2 motifs, which contain the integrin binding site, failed to form integrin clusters or to spread on a substrate for beta1- and beta3-integrins. These results 1) suggest a dynamic reorganization of integrin complexes during cell spreading, 2) show that different cytoskeletal proteins link integrins in different complexes, and 3) demonstrate that skelemin is responsible for linking integrin to the calpain-induced clusters, and 4) show that the integrin-skelemin interaction is essential for transmission of signals leading to the initial steps of cell spreading.


Subject(s)
Cytoskeletal Proteins/metabolism , Cytoskeletal Proteins/physiology , Cytoskeleton/metabolism , Integrins/metabolism , Actinin/chemistry , Actinin/metabolism , Amino Acid Motifs , Amino Acid Sequence , Animals , Antigens, CD/metabolism , CHO Cells , Calpain/metabolism , Cattle , Cell Line , Connectin , Cricetinae , Endothelium, Vascular/cytology , Enzyme Activation , Fibroblasts/metabolism , Fibronectins/metabolism , Focal Adhesions , Green Fluorescent Proteins , Humans , Integrin beta3 , Luminescent Proteins/metabolism , Mice , Mice, Inbred C3H , Microscopy, Confocal , Microscopy, Fluorescence , Molecular Sequence Data , Muscle Proteins , Plasmids/metabolism , Platelet Membrane Glycoproteins/metabolism , Precipitin Tests , Protein Binding , Rats , Signal Transduction , Talin/metabolism , Transfection
13.
J Clin Invest ; 107(8): 975-84, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11306601

ABSTRACT

Mice lacking natriuretic peptide receptor A (NPRA) have marked cardiac hypertrophy and chamber dilatation disproportionate to their increased blood pressure (BP), suggesting, in support of previous in vitro data, that the NPRA system moderates the cardiac response to hypertrophic stimuli. Here, we have followed the changes in cardiac function in response to altered mechanical load on the heart of NPRA-null mice (Npr1-/-). Chronic treatment with either enalapril, furosemide, hydralazine, or losartan were all effective in reducing and maintaining BP at normal levels without affecting heart weight/body weight. In the reverse direction, we used transverse aortic constriction (TAC) to induce pressure overload. In the Npr1-/- mice, TAC resulted in a 15-fold increase in atrial natriuretic peptide (ANP) expression, a 55% increase in left ventricular weight/body weight (LV/BW), dilatation of the LV, and significant decline in cardiac function. In contrast, banded Npr1+/+ mice showed only a threefold increase in ANP expression, an 11% increase in LV/BW, a 0.2 mm decrease in LV end diastolic dimension, and no change in fractional shortening. The activation of mitogen-activated protein kinases that occurs in response to TAC did not differ in the Npr1+/+ and Npr1-/- mice. Taken together, these results suggest that the NPRA system has direct antihypertrophic actions in the heart, independent of its role in BP control.


Subject(s)
Cardiomegaly/physiopathology , Guanylate Cyclase/physiology , Receptors, Atrial Natriuretic Factor/physiology , Animals , Antihypertensive Agents/therapeutic use , Blood Pressure , Cardiomegaly/drug therapy , Cardiomegaly/metabolism , Enalapril/therapeutic use , Furosemide/therapeutic use , Hydralazine/therapeutic use , Losartan/therapeutic use , Mice , Mice, Inbred C57BL , Mice, Knockout , Mitogen-Activated Protein Kinases/metabolism , Myocardium/pathology , Organ Size , Propranolol/therapeutic use , Telemetry/methods , Ventricular Dysfunction, Left/physiopathology
14.
ScientificWorldJournal ; 1: 653-5, 2001 Nov 13.
Article in English | MEDLINE | ID: mdl-12805768

ABSTRACT

Endocrine disrupting chemicals (EDCs) include organochlorine pesticides, plastics manufacturing by-products, and certain herbicides. These chemicals have been shown to disrupt hormonal signaling in exposed wildlife, lab animals, and mammalian cell culture by binding to estrogen receptors (ER-+/- and ER-) and affecting the expression of estrogen responsive genes. Additionally, certain plant chemicals, termed phytoestrogens, are also able to bind to estrogen receptors and modulate gene expression, and as such also may be considered EDCs. One example of phytoestrogen action is genistein, a phytochemical produced by soybeans, binding estrogen receptors, and changing expression of estrogen responsive genes which certain studies have linked to a lower incidence of hormonally related cancers in Japanese populations. Why would plants make compounds that are able to act as estrogens in the human body? Obviously, soybeans do not intentionally produce phytoestrogens to prevent breast cancer in Japanese women.


Subject(s)
Endocrine System/drug effects , Gene Expression Regulation, Bacterial/drug effects , Gene Expression Regulation, Bacterial/genetics , Herbicides/pharmacology , Hydrocarbons, Chlorinated , Insecticides/pharmacology , Symbiosis/drug effects , Symbiosis/genetics , Animals , Gene Expression Regulation, Bacterial/physiology , Humans , Isoflavones/antagonists & inhibitors , Isoflavones/physiology , Phytoestrogens , Plant Preparations/antagonists & inhibitors , Plants/chemistry , Symbiosis/physiology , Transcriptional Activation
15.
J Physiol ; 529 Pt 2: 285-93, 2000 Dec 01.
Article in English | MEDLINE | ID: mdl-11101640

ABSTRACT

Monocarboxylate transporter (MCT) 4 is the major monocarboxylate transporter isoform present in white skeletal muscle and is responsible for the efflux of lactic acid produced by glycolysis. Here we report the characterisation of MCT4 expressed in Xenopus oocytes. The protein was correctly targeted to the plasma membrane and rates of substrate transport were determined from the rate of intracellular acidification monitored with the pH-sensitive dye 2', 7'-bis-(carboxyethyl)-5(6)-carboxyfluorescein (BCECF). In order to validate the technique, the kinetics of monocarboxylate transport were measured in oocytes expressing MCT1. Km values determined for L-lactate, D-lactate and pyruvate of 4.4, > 60 and 2.1 mM, respectively, were similar to those determined previously in tumour cells. Comparison of the time course of [14C]lactate accumulation with the rate of intracellular acidification monitored with BCECF suggests that the latter reflects pH changes close to the plasma membrane associated with transport, whilst the former may include diffusion-limited movement of lactate into the bulk cytosol. Km values of MCT4 for these substrates were found to be 28, 519 and 153 mM, respectively, and for a range of other monocarboxylates values were at least an order of magnitude higher than for MCT1. Vmax values appeared to be similar for all substrates. K0.5 values of MCT4 (determined at 30 mM L-lactate) for inhibition by alpha-cyano-4-hydroxycinnamate (991 microM), phloretin (41 microM), 5-nitro-2-(3-phenylpropylamino)benzoate (240 microM), p-chloromercuribenzene sulphonate (21 microM) and 3-isobutyl-1-methylxanthine (970 microM, partial inhibition) were also substantially higher than for MCT1. No inhibition of MCT4 by 2 mM 4,4'-diisothiocyanostilbene-2,2'-disulphonate was observed. The properties of MCT4 are consistent with published data on giant sarcolemmal vesicles in which MCT4 is the dominant MCT isoform, and are appropriate for the proposed role of MCT4 in mediating the efflux from the cell of glycolytically derived lactic acid but not pyruvate.


Subject(s)
Carrier Proteins/physiology , Lactic Acid/metabolism , Monocarboxylic Acid Transporters , Muscle Proteins , Muscle, Skeletal/enzymology , Animals , Biological Transport, Active/drug effects , Carrier Proteins/antagonists & inhibitors , Carrier Proteins/genetics , Cells, Cultured , Fluoresceins/chemistry , Fluorescent Dyes/chemistry , Humans , Kinetics , Muscle, Skeletal/metabolism , Oocytes/metabolism , Protein Isoforms/physiology , Substrate Specificity , Xenopus
16.
J Cell Biol ; 151(3): 685-96, 2000 Oct 30.
Article in English | MEDLINE | ID: mdl-11062268

ABSTRACT

Interaction of integrins with the extracellular matrix leads to transmission of signals, cytoskeletal reorganizations, and changes in cell behavior. While many signaling molecules are known to be activated within Rac-induced focal complexes or Rho-induced focal adhesions, the way in which integrin-mediated adhesion leads to activation of Rac and Rho is not known. In the present study, we identified clusters of integrin that formed upstream of Rac activation. These clusters contained a Rac-binding protein(s) and appeared to be involved in Rac activation. The integrin clusters contained calpain and calpain-cleaved beta3 integrin, while the focal complexes and focal adhesions that formed once Rac and Rho were activated did not. Moreover, the integrin clusters were dependent on calpain for their formation. In contrast, while Rac- and Rho-GTPases were dependent on calpain for their activation, formation of focal complexes and focal adhesions by constitutively active Rac or Rho, respectively, occurred even when calpain inhibitors were present. Taken together, these data are consistent with a model in which integrin-induced Rac activation requires the formation of integrin clusters. The clusters form in a calpain-dependent manner, contain calpain, calpain-cleaved integrin, and a Rac binding protein(s). Once Rac is activated, other integrin signaling complexes are formed by a calpain-independent mechanism(s).


Subject(s)
Antigens, CD/metabolism , Calpain/metabolism , Focal Adhesions/metabolism , Platelet Membrane Glycoproteins/metabolism , rac GTP-Binding Proteins/metabolism , rhoA GTP-Binding Protein/metabolism , Amino Acid Substitution/genetics , Animals , Aorta , Calpain/antagonists & inhibitors , Calpain/genetics , Cattle , Cell Adhesion , Cell Size , Cell Surface Extensions/metabolism , Cells, Cultured , Endothelium, Vascular/cytology , Endothelium, Vascular/enzymology , Endothelium, Vascular/metabolism , Enzyme Activation , Fibronectins/metabolism , Focal Adhesions/chemistry , Genes, Dominant/genetics , Humans , Integrin beta3 , Macromolecular Substances , Models, Biological , Mutation/genetics , Protein Binding , Protein Processing, Post-Translational , Signal Transduction , Vinculin/metabolism , Vitronectin/metabolism , rhoA GTP-Binding Protein/genetics
17.
J Biol Chem ; 275(22): 16779-87, 2000 Jun 02.
Article in English | MEDLINE | ID: mdl-10828063

ABSTRACT

In platelets, alpha(IIb)beta(3) exists in a form that cannot bind adhesive proteins in the plasma; although it can interact with immobilized fibrinogen it cannot interact with immobilized von Willebrand factor in the vessel wall. Soluble agonists such as thrombin convert alpha(IIb)beta(3) to a form that recognizes soluble and immobilized ligands. Attempts to reconstitute alpha(IIb)beta(3) activation in a non-hematopoietic, nucleated cell system have been unsuccessful. In the present study, we have developed a transfected Chinese hamster ovary cell model in which alpha(IIb)beta(3) activation is induced by signaling across glycoprotein (GP) Ib-IX by its ligand, von Willebrand factor. GPIb-IX activates not only the transfected alpha(IIb)beta(3) but also endogenous alpha(v)beta(3). Activation of the pathways leading to integrin activation occurred even in cells transfected with GPIb-IX lacking the domain on GPIbalpha that binds 14-3-3 or that which binds actin-binding protein. These studies demonstrate that signals induced by interaction of GPIb-IX with von Willebrand factor lead to alpha(IIb)beta(3) activation and suggest that the signaling pathways by which GPIb-IX induces alpha(IIb)beta(3) activation are different to those used by thrombin. Elucidation of these differences may provide insights into therapeutic ways in which to inhibit integrin activation in selective clinical settings.


Subject(s)
Blood Platelets/metabolism , Platelet Glycoprotein GPIIb-IIIa Complex/metabolism , Platelet Glycoprotein GPIb-IX Complex/metabolism , Signal Transduction , Animals , CHO Cells , Cricetinae , Cricetulus , Cytoplasm/metabolism , Transfection
19.
Biologist (London) ; 47(1): 31-4, 2000 Feb.
Article in English | MEDLINE | ID: mdl-11190217

ABSTRACT

Sandalwood is the most valuable tree in the world. As with gold, platinum and diamonds, it owes its value to a demand based on ritual, fashion and scarcity. It is the stuff of mystery and intrigue, and fortunes can still be made from it.


Subject(s)
Trees , Australia , India , Magnoliopsida , Plants, Medicinal , Trees/growth & development , Trees/physiology
20.
Am J Med Genet ; 95(4): 381-4, 2000 Dec 11.
Article in English | MEDLINE | ID: mdl-11186894

ABSTRACT

Trisomy 4 mosaicism is rare. To our knowledge only two cases of prenatally diagnosed trisomy 4 mosaicism have been reported. One case resulted in a normal liveborn male, the other resulted in an abnormal liveborn female. The karyotype of our case at the time of amniocentesis was 47,XY,+4[3]/ 46,XY[33] and resulted in a normal liveborn male. FISH analysis using an alpha satellite chromosome 4 probe was performed to confirm the cytogenetic findings. Follow-up chromosome analysis of cord blood, peripheral blood, foreskin, and umbilical cord fibroblasts showed a normal 46,XY male karyotype in all cells. FISH analysis of cord blood, umbilical cord fibroblasts, and amniotic fluid cells demonstrated two signals in 246 nuclei (i.e., 46,XY) and three signals in six nuclei (i.e., 47,XY,+4). Here we describe the present case of trisomy 4 mosaicism, the literature is reviewed, and the significance of this finding is discussed.


Subject(s)
Chromosomes, Human, Pair 4/genetics , Mosaicism/genetics , Prenatal Diagnosis , Trisomy/genetics , Adult , Africa/ethnology , Black People/genetics , Female , Humans , Infant, Newborn , Jamaica/ethnology , Karyotyping , Male , Mosaicism/diagnosis , New York/epidemiology , Pregnancy , Prenatal Diagnosis/methods , Trisomy/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...